In 3000 patients with AF eligible for anticoagulation, left atrial appendage closure was non-inferior to NOAC therapy for CV death, stroke or systemic embolism at 3 years (5.7% vs 4.8%) and reduced non-procedure-related bleeding (10.9% vs 19.0%; HR 0.55).
RCTn = 3,000
Doshi et al. Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation